香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 – 1 – (a) 本公司執行董事兼主席陳建正先生（「陳先生」）已不再擔任提名委員會成員，並 獲委任為薪酬委員會成員；及 (b) 執行董事趙理女士（「趙女士」）已獲委任為提名委員會成員，並不再擔任薪酬委 員會成員。 提名委員會及薪酬與考核委員會組成的變動 靈寶黃金集團股份有限公司（「本公司」）董事（「董事」）會（「董事會」）謹此宣佈，為回 應香港聯合交易所有限公司證券上市規則（「上市規則」）附錄C1所載自二零二五年 七月一日起生效的經修訂企業管治守則，本公司提名委員會（「提名委員會」）及薪酬 與考核委員會（「薪酬委員會」）的組成有以下變動，自二零二五年八月二十六日起生 效： Lingbao Gold Group Company Ltd. 於本公告日期，陳先生及趙女士於董事會及相關董事會委員會（如適用）擔任的其他 職務並無變動。 靈寶黃金集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份 ...

EF001 免責聲明 | 香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因 | | | | --- | --- | --- | | 公告全部或任何部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 | | | | 股票發行人現金股息公告 | | | | 發行人名稱 | 靈寶黃金集團股份有限公司 | | | 股份代號 | 03330 | | | 多櫃檯股份代號及貨幣 | 不適用 | | | 相關股份代號及名稱 | 不適用 | | | 公告標題 | 建議截至2025年6月30日止六個月的中期股息 | | | 公告日期 | 2025年8月26日 | | | 公告狀態 | 新公告 | | | 股息信息 | | | | 股息類型 | 中期（半年期） | | | 股息性質 | 普通股息 | | | 財政年末 | 2025年12月31日 | | | 宣派股息的報告期末 | 2025年6月30日 | | | 宣派股息 | 每 股 0.164 RMB | | | 股東批准日期 | 2025年9月17日 | | | 香港過戶登記處相關信息 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 Lingbao Gold Group Company Ltd. 靈寶黃金集團股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：3330） 截至二零二五年六月三十日止六個月 中期業績公佈 靈寶黃金集團股份有限公司（「本公司」）董事（「董事」）會（「董事會」）欣然公佈本公司及其 附屬公司（統稱「本集團」或「我們」）截至二零二五年六月三十日止六個月（「本期間」）的未 經審核中期業績。此中期財務業績已經本公司審核委員會（「審核委員會」）審閱。另外， 本集團之外部核數師已按照香港會計師公會（「香港會計師公會」）頒佈的香港審閱工作準 則第2410號「實體的獨立核數師審閱中期財務資料」審閱中期財務報告。 – 1 – 簡明綜合損益表 截至二零二五年六月三十日止六個月 — 未經審核 （以人民幣元表示） | | | 截至 | 截至 | | --- | --- | --- | --- | | | | 二零 ...

Market Overview - US stock indices experienced adjustments, with European markets also facing challenges, particularly in France where the CAC 40 index fell over 2% [1] - Hong Kong stocks corrected after a strong rally, closing down 1.18% [1] - Optimism regarding potential Fed rate cuts was tempered by concerns over Trump's threats to dismiss Fed Governor Lisa Cook, which could undermine confidence in USD assets [1] Gold and Mining Sector - Gold stocks surged, with China Gold International reporting a turnaround in its mid-year results, showing strong growth and significant capacity expansion potential [1] - Other gold stocks like Lingbao Gold and Zhaojin Mining also saw substantial gains, reflecting a broader trend in the sector [1] Trade and Tariff Implications - Trump threatened to impose approximately 200% tariffs on rare earth magnets from China and additional tariffs on countries implementing digital taxes, impacting major US tech companies [2] - The US government proposed adding copper, silicon, and silver to a list of critical minerals, indicating a shift in tariff strategy to protect domestic industries [2] Automotive Industry Dynamics - The automotive sector is undergoing rapid changes, with Chinese electric vehicle companies and Tesla significantly shortening the development cycle for new models to about two years [3] - Traditional players like Puma are exploring strategic options, including potential sales, indicating a shift in competitive dynamics within the industry [3] AI and Technology Sector - The Chinese government announced plans to integrate AI with six key sectors by 2027, which will drive capital expenditure towards AI-related technologies [6] - Companies like SMIC and SenseTime are positioned to benefit from increased investment in AI and related technologies [6] Company Performance Highlights - Angelalign reported a 33.1% increase in revenue to $161.4 million, with a significant rise in net profit, indicating strong performance in the orthodontics market [4] - Meituan was included in the MSCI China Index, leading to an 8% increase in its stock price [5] Individual Stock Insights - SenseTime is expected to report improved financial results, with projected revenue growth and a potential narrowing of losses, reflecting a positive outlook for the company [7] - The company has a strong competitive position in AI technology, with significant advancements in model capabilities and market share in various applications [8]

Market Overview - The Hong Kong stock market failed to maintain its strong performance from the previous day, with all three major indices experiencing a collective adjustment. The Hang Seng Index fell by 1.18% or 304.99 points, closing at 25,524.92 points, with a total trading volume of HKD 31.78 billion. The Hang Seng China Enterprises Index decreased by 1.07% to 9,148.66 points, while the Hang Seng Tech Index dropped by 0.74% to 5,782.24 points [1] Blue-Chip Stocks Performance - CSPC Pharmaceutical Group (01093) led the decline among blue-chip stocks, falling by 4.33% to HKD 10.38, with a trading volume of HKD 1.797 billion, contributing a loss of 6.04 points to the Hang Seng Index. Bank of America Securities reported a 14.3% year-on-year decline in total revenue for CSPC in Q2, with attributable net profit down 24% to RMB 1.1 billion. The firm revised its revenue forecasts for 2025 to 2027 down by 25%, 2%, and 11% respectively [2] Sector Highlights - Large technology stocks mostly declined, with Alibaba down 2.57% and Tencent down 0.81%. Gold stocks surged, with China Gold International rising over 10%. Apple is expected to initiate a three-year innovation cycle, boosting related stocks like Lens Technology, which rose over 5%. Gaming stocks and some new consumption concepts performed well, with Melco International Development up over 9% [3][5] Federal Reserve Insights - Federal Reserve Chairman Jerome Powell indicated rising downside risks in the U.S. labor market, suggesting a potential policy adjustment could be appropriate. This statement is seen as a strong signal for a possible interest rate cut as early as September. The market reacted positively, particularly for precious metals, with expectations for further increases in gold prices [4] Gaming Sector Performance - The gaming sector continued its upward trend, with Melco International Development rising 9.27% to HKD 5.54. According to JPMorgan, Macau's gaming revenue for the first 24 days of August reached MOP 17.65 billion, with a daily average of MOP 735 million, reflecting a 9% increase from the previous week [6] Pharmaceutical Sector Challenges - The pharmaceutical sector faced pressure, with several stocks declining. Notably, CStone Pharmaceuticals (09966) fell 6.74% to HKD 10.24. U.S. President Trump's announcement to drastically reduce drug prices could create significant challenges for the global pharmaceutical industry, presenting both opportunities and risks for Chinese biotech stocks [6] Notable Stock Movements - Double Ended Co. (06960) debuted with a 31.29% increase, closing at HKD 19.05. The company focuses on energy storage solutions in the data and communication sectors, with a projected market share of 11.1% by 2024 [7] - Kingsoft Holdings (03918) reached a new high, rising 17.94% to HKD 5.72, reporting a 16.76% year-on-year revenue increase to USD 342 million [8] - Angelalign Technology (06699) saw a 10.28% increase to HKD 75.1, with a 33.1% year-on-year revenue growth reported [9] - Meitu Inc. (01357) rose 7.9% to HKD 11.47 after being included in the MSCI China Index, with Morgan Stanley expressing confidence in its long-term growth potential [10] - Xintai Medical (02291) experienced a significant drop of 12.75% to HKD 23.96 following a major shareholder's sale of shares [11]

| 指数 | 最新 | 涨跌幅 | | --- | --- | --- | | 相生指数 | 25524.92 | -1.18% | | 国企指数 | 9148.66 | -1.07% | | 红筹指数 | 4343.85 | -1.02% | 免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 每经AI快讯：北京时间8月26日16:00，恒生指数收盘下跌304.99点，跌幅为1.18%，报收25524.92点；国 企指数收盘下跌99.34点，跌幅为1.07%，报收9148.66点；红筹指数收盘下跌44.65点，跌幅为1.02%，报 收4343.85点。南向资金当日净流入165.73亿港元。东方甄选跌超11%，蔚来、君实生物跌超6%，中兴 通讯跌近6%，碧桂园跌超5%；中国黄金国际涨超10%，灵宝黄金涨超9%。 （记者 胡玲） ...

消息面上，美联储主席鲍威尔周五在杰克逊霍尔全球央行年会上表示，美国就业市场面临的下行风险上 升，风险的平衡转变可能使得美联储调整政策立场成为恰当之举。这是鲍威尔迄今为止发出的最强烈的 信号，暗示美联储最早将于9月降息。华鑫证券指，美联储仍处于降息周期，鲍威尔发言为贵金属市场 注入强心剂，看好黄金价格进一步上涨。另值得关注的是，据报道，特朗普在社交媒体高调宣布，解除 美联储理事丽莎·库克（Lisa Cook）职务"立即生效"，此举引发对联储独立性的担忧。 黄金股再度走高，截至发稿，中国黄金（600916）国际(02099)涨6.46%，报94.8港元；灵宝黄金(03330) 涨6.08%，报12.22港元；招金矿业(01818)涨3.78%，报22.5港元；山东黄金（600547）(01787)涨 3.54%，报28.66港元。 ...

消息面上，美联储主席鲍威尔周五在杰克逊霍尔全球央行年会上表示，美国就业市场面临的下行风险上 升，风险的平衡转变可能使得美联储调整政策立场成为恰当之举。这是鲍威尔迄今为止发出的最强烈的 信号，暗示美联储最早将于9月降息。华鑫证券指，美联储仍处于降息周期，鲍威尔发言为贵金属市场 注入强心剂，看好黄金价格进一步上涨。另值得关注的是，据报道，特朗普在社交媒体高调宣布，解除 美联储理事丽莎·库克（Lisa Cook）职务"立即生效"，此举引发对联储独立性的担忧。 智通财经APP获悉，黄金股再度走高，截至发稿，中国黄金国际(02099)涨6.46%，报94.8港元；灵宝黄 金(03330)涨6.08%，报12.22港元；招金矿业(01818)涨3.78%，报22.5港元；山东黄金(01787)涨3.54%， 报28.66港元。 ...

港股黄金股逆势上涨，其中，灵宝黄金涨4.5%，潼关黄金涨3.6%，山东黄金、招金矿业、中国黄金国 际涨超3%，赤峰黄金、紫金矿业涨超1%。 消息上，亚洲早盘现货黄金由跌转涨至0.6%，一度重回3380美元/盎司。随着美联储主席鲍威尔在8月22 日杰克逊霍尔举行的年度经济研讨会上释放明确的"鸽派"信号，扭转前期关于降息预期的摇摆，9月降 息概率大幅增加。 有机构认为，随着美联储9月降息预期大幅提升，名义利率的下降与通胀预期的反弹或将带动实际利率 快速下降，从而利好黄金定价，金价上涨的逻辑更为清晰。(格隆汇) | 代码 | 名称 | 最新价 | 涨跌幅 ▽ | | --- | --- | --- | --- | | 03330 | 灵宝黄金 | 12.040 | 4.51% | | 00340 | 漳关黄金 | 2.000 | 3.63% | | 01787 | 山东黄金 | 28.600 | 3.32% | | 01818 | 招金矿业 | 22.420 | 3.41% | | 02099 | 中国黄金国际 | 92.000 | 3.31% | | 06693 | 赤峰黄金 | 25.160 | 1.29% | ...

Group 1 - The Hong Kong stock market indices collectively strengthened on August 25, with the Hang Seng Index rising over 2% during the day, reaching a nearly four-year high of 25918.86 points [1] - By the end of the trading day, the Hang Seng Index closed up 1.94% at 25829.91 points, the Hang Seng Tech Index increased by 3.14% to 5825.09 points, and the National Enterprises Index rose by 1.85% to 9248 points [1] - Technology stocks were a significant driver of the index's rise, with notable gains from companies such as NetEase (+6.04%), Alibaba (+5.51%), Kuaishou (+5.14%), JD Group (+4.28%), Meituan (+3.29%), SenseTime (+2.72%), Tencent (+2.42%), and Xiaomi (+1.81%) [1] Group 2 - Gold stocks also saw significant increases, with Everest Gold rising by 11.31%, Zijin Mining by 6.38%, Lingbao Gold by 5.21%, China Gold International by 4.95%, Tongguan Gold by 4.32%, Shandong Gold by 3.75%, Chifeng Jilong Gold by 2.99%, and Zhaojin Mining by 1.31% [1] - Futu Securities' chief analyst noted that the positive performance of the Hong Kong stock market is beneficial for the real economy, improving financing channels for innovative industries [1] - Companies in sectors such as artificial intelligence, autonomous driving, and innovative pharmaceuticals may utilize IPOs or other financing methods to raise funds, leading to more active development of new projects and positively impacting the job market [1][2]